Table 4. Toxicity profile of selected thioazo compounds (1-6).
| Toxicity | |||||||
| Compound | aLD50 (mg/kg) | Class | HEPATOTOXICITY | CARCINOGENICITY | IMMUNOTOXICITY | MUTAGENICITY | CYTOTOXICITY |
| 1 | 300mg/kg | 3 | Active | Inactive | Active | Inactive | Inactive |
| 2 | 300mg/kg | 3 | Active | Inactive | Active | Inactive | Inactive |
| 3 | 3000mg/kg | 5 | Inactive | Inactive | Active | Inactive | Inactive |
| 4 | 3000mg/kg | 5 | Inactive | Inactive | Active | Inactive | Inactive |
| 5 | 300mg/kg | 3 | Active | Active | Inactive | Active | Inactive |
| 6 | 1000mg/kg | 4 | Active | Active | Active | Active | Inactive |
| Doxorubicin | 205mg/kg | 3 | Inactive | Inactive | Active | Active | Active |
| Paclitaxel | 134mg/kg | 3 | Inactive | Inactive | Active | Inactive | Active |
| Tamoxifen | 1190mg/kg | 4 | Active | Inactive | Active | Inactive | Inactive |
| a LD50: lethal dose parameter |